Loading people...
Chris Angelatos is a Vice President at Vistara Growth based in Toronto, Ontario, Canada. Prior to his current position, he served as an Associate at Esplanade HealthTech Ventures, where he spent three years sourcing and executing global investments in the healthcare IT and technology-enabled services sectors. He previously worked on the Mid-Market Technology and Innovation Investment Banking team at CIBC, focusing on growth equity and mergers and acquisitions for emerging technology companies. Earlier in his career, Angelatos was the Co-founder and CEO of Lumos Energy Strips and was selected for The Next 36 program for high-potential entrepreneurs. He holds a Bachelor of Applied Science in Engineering Chemistry from Queen's University, which he earned between 2012 and 2016. Today, his professional background combines early-stage technology entrepreneurship with extensive experience in corporate finance and growth equity investing.
Chris Angelatos is a dedicated Associate at Esplanade HealthTech Ventures, a prominent venture capital firm committed to investing in the future of healthcare through technology. In his role, Chris is instrumental in the firm's mission to identify, analyze, and support innovative startups that are poised to disrupt and enhance the health technology landscape. His responsibilities typically include conducting thorough due diligence, market research, and financial analysis to assess the potential of prospective investments.
Esplanade HealthTech Ventures, with Chris Angelatos as a key team member, focuses on a broad spectrum of health technology areas. These often include digital health platforms, artificial intelligence and machine learning applications in diagnostics and treatment, telehealth solutions, medical devices, biotechnology innovations, and software designed to streamline healthcare operations. Chris actively seeks out companies that demonstrate strong potential for growth, possess unique intellectual property, and are led by visionary teams committed to making a significant impact on healthcare outcomes.
While specific details of Chris Angelatos's career background are not publicly detailed, individuals in his position at leading venture capital firms typically bring a robust foundation in finance, technology, healthcare, or a combination thereof. This often includes experience in investment banking, consulting, entrepreneurship, or scientific research, all of which provide a critical lens for evaluating complex healthtech ventures. His passion for innovation and understanding of market dynamics are crucial in identifying the next generation of healthcare leaders.
At Esplanade HealthTech Ventures, the investment strategy is centered on providing not just capital, but also strategic guidance and operational support to portfolio companies. Chris Angelatos contributes to this holistic approach, working alongside founders to help them navigate challenges, scale their operations, and achieve their strategic milestones. While specific notable investments by Chris Angelatos are typically confidential or attributed to the firm as a whole, his contributions are vital to the firm's success in backing companies that are shaping the future of health.
Chris Angelatos's work at Esplanade HealthTech Ventures underscores the firm's commitment to fostering advancements that can lead to more efficient, accessible, and effective healthcare solutions globally. His analytical skills and dedication to the healthtech ecosystem make him a valuable asset in the venture capital community.
Chris Angelatos is an Associate at Esplanade HealthTech Ventures, a venture capital firm specializing in health technology investments. He is involved in identifying, evaluating, and supporting innovative startups within the healthtech sector.
As an Associate at Esplanade HealthTech Ventures, Chris Angelatos focuses on investments in health technology companies. This includes areas such as digital health, AI in healthcare, telehealth, medical devices, biotechnology, and software solutions aimed at improving healthcare.
Chris Angelatos works as an Associate at Esplanade HealthTech Ventures, a venture capital firm dedicated to investing in and supporting the next generation of health technology companies.
